Champions Oncology, Inc.
CSBR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000771856
No open-market purchases or sales by Champions Oncology, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $36.3M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Champions Oncology, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +1 vs. Q4 2022
- Shares held
- 5.86M
- −143.0K (−2.4%) vs. Q4 2022
- Total value
- $23.6M
- −$3.52M (−13.0%) vs. Q4 2022
- New holders
- 2
- 8 more added
- Sold out
- 1
- 6 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CSBR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $36.3M |
| Q1 2026 | 25 | $33.0M |
| Q4 2025 | 27 | $39.7M |
| Q3 2025 | 27 | $36.7M |
| Q2 2025 | 30 | $42.5M |
| Q1 2025 | 34 | $51.4M |
| Q4 2024 | 25 | $49.0M |
| Q3 2024 | 22 | $28.2M |
| Q2 2024 | 23 | $29.9M |
| Q1 2024 | 25 | $27.6M |
| Q4 2023 | 23 | $31.5M |
| Q3 2023 | 29 | $35.6M |
| Q2 2023 | 28 | $37.0M |
| Q1 2023 | 30 | $23.6M |
| Q4 2022 | 29 | $27.1M |
| Q3 2022 | 32 | $46.8M |
| Q2 2022 | 32 | $49.8M |
| Q1 2022 | 30 | $50.4M |
| Q4 2021 | 31 | $51.7M |
| Q3 2021 | 35 | $64.1M |
| Q2 2021 | 38 | $68.5M |
| Q1 2021 | 45 | $81.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Champions Oncology, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Battery Management Corp. | 2,421,673 | $9.74M | 1.40% | 00.0% | Unchanged |
| NEA Management Company, LLC | 1,713,720 | $6.89M | 0.48% | 00.0% | Unchanged |
| Tocqueville Asset Management L.P. | 665,428 | $2.68M | 0.05% | +50,200+8.2% | Added |
| Renaissance Technologies LLC | 126,491 | $508.0K | 0.00% | −7,400−5.5% | Reduced |
| Dimensional Fund Advisors LP | 116,291 | $467.5K | 0.00% | −5,514−4.5% | Reduced |
| BlackRock Inc. | 115,847 | $465.7K | 0.00% | −6,211−5.1% | Reduced |
| Essex Investment Management Co LLC | 107,655 | $432.8K | 0.06% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 80,776 | $324.7K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 68,007 | $273.4K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 60,253 | $242.0K | 0.00% | +1,051+1.8% | Added |
| Geode Capital Management, LLC | 50,452 | $202.8K | 0.00% | +20.0% | Added |
| Overbrook Management Corp | 48,488 | $194.9K | 0.05% | −5,400−10.0% | Reduced |
| HighTower Advisors, LLC | 31,238 | $126.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 31,476 | $124.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 30,775 | $123.7K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 28,786 | $115.7K | 0.00% | +673+2.4% | Added |
| State Street Corp | 26,553 | $106.7K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 25,830 | $103.8K | 0.00% | +25,830 | New |
| Stifel Financial Corp | 22,325 | $89.7K | 0.00% | +22,325 | New |
| Aristides Capital LLC | 21,622 | $86.9K | 0.05% | 00.0% | Unchanged |
| Susquehanna Fundamental Investments, LLC | 20,619 | $82.9K | 0.00% | −2,481−10.7% | Reduced |
| Citadel Advisors LLC | 12,484 | $50.2K | 0.00% | −25,533−67.2% | Reduced |
| Ingalls & Snyder LLC | 11,056 | $44.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 9,100 | $36.6K | 0.00% | +1,206+15.3% | Added |
| Globeflex Capital L P | 8,549 | $34.4K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,657 | $10.0K | 0.00% | +698+35.6% | Added |
| Royal Bank of Canada | 1,666 | $7.00K | 0.00% | +1,518+1,025.7% | Added |
| Steward Financial Group LLC | 775 | $3.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 43 | $173 | 0.00% | +1+2.4% | Added |
| JPMorgan Chase & Co | 11 | $0 | 0.00% | 00.0% | Unchanged |
| Millrace Asset Group, Inc. | 0 | $0 | 0.00% | −194,010−100.0% | Sold out |